985 related articles for article (PubMed ID: 15150185)
1. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
2. Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
Ortiz-Ruiz G; Vetter N; Isaacs R; Carides A; Woods GL; Friedland I
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii59-66. PubMed ID: 15150184
[TBL] [Abstract][Full Text] [Related]
3. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
Roy S; Higareda I; Angel-Muller E; Ismail M; Hague C; Adeyi B; Woods GL; Teppler H;
Infect Dis Obstet Gynecol; 2003; 11(1):27-37. PubMed ID: 12839630
[TBL] [Abstract][Full Text] [Related]
4. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
Tomera KM; Burdmann EA; Reyna OG; Jiang Q; Wimmer WM; Woods GL; Gesser RM;
Antimicrob Agents Chemother; 2002 Sep; 46(9):2895-900. PubMed ID: 12183244
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Gesser RM; McCarroll K; Teppler H; Woods GL
J Antimicrob Chemother; 2003 May; 51(5):1253-60. PubMed ID: 12697633
[TBL] [Abstract][Full Text] [Related]
6. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
[TBL] [Abstract][Full Text] [Related]
7. A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.
Jimenez-Cruz F; Jasovich A; Cajigas J; Jiang Q; Imbeault D; Woods GL; Gesser RM;
Urology; 2002 Jul; 60(1):16-22. PubMed ID: 12100914
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
[TBL] [Abstract][Full Text] [Related]
9. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
Graham DR; Lucasti C; Malafaia O; Nichols RL; Holtom P; Perez NQ; McAdams A; Woods GL; Ceesay TP; Gesser R
Clin Infect Dis; 2002 Jun; 34(11):1460-8. PubMed ID: 12015692
[TBL] [Abstract][Full Text] [Related]
10. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.
Park DW; Peck KR; Chung MH; Lee JS; Park YS; Kim HY; Lee MS; Kim JY; Yeom JS; Kim MJ
J Korean Med Sci; 2012 May; 27(5):476-83. PubMed ID: 22563210
[TBL] [Abstract][Full Text] [Related]
12. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis: ertapenem for complicated intra-abdominal infections.
Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
15. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
Vetter N; Cambronero-Hernandez E; Rohlf J; Simon S; Carides A; Oliveria T; Isaacs R;
Clin Ther; 2002 Nov; 24(11):1770-85. PubMed ID: 12501873
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment for urinary tract infections in pediatric patients.
Hellerstein S
Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of ertapenem.
Teppler H; Gesser RM; Friedland IR; Woods GL; Meibohm A; Herman G; Mistry G; Isaacs R
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii75-81. PubMed ID: 15150186
[TBL] [Abstract][Full Text] [Related]
19. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Dow G; Rao P; Harding G; Brunka J; Kennedy J; Alfa M; Nicolle LE
Clin Infect Dis; 2004 Sep; 39(5):658-64. PubMed ID: 15356779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
